Show simple item record

dc.creatorPan, Xiaoqi
dc.creatorDong, Lan
dc.creatorYang, Lian
dc.creatorChen, Dayi
dc.creatorPeng, Cheng
dc.date.accessioned2020-07-31T20:59:13Z
dc.date.available2020-07-31T20:59:13Z
dc.date.created2020
dc.identifier.issn0168-1702spa
dc.identifier.otherhttps://doi.org/10.1016/j.virusres.2020.198057spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/11503
dc.description.abstractThe fight against the novel coronavirus pneumonia (namely COVID-19) that seriously harms human health is a common task for all mankind. Currently, development of drugs against the novel coronavirus (namely SARSCoV-2) is quite urgent. Chinese medical workers and scientific researchers have found some drugs to play potential therapeutic effects on COVID-19 at the cellular level or in preliminary clinical trials. However, more fundamental studies and large sample clinical trials need to be done to ensure the efficacy and safety of these drugs. The adoption of these drugs without further testing must be careful. The relevant articles, news, and government reports published on the official and Preprint websites, PubMed and China National Knowledge Infrastructure (CNKI) databases from December 2019 to April 2020 were searched and manually filtered. The general pharmacological characteristics, indications, adverse reactions, general usage, and especially current status of the treatment of COVID-19 of those potentially effective drugs, including chemical drugs, traditional Chinese medicines (TCMs), and biological products in China were summarized in this review to guide reasonable medication and the development of specific drugs for the treatment of COVID-19.spa
dc.format.extent12 páginasspa
dc.format.mimetypeimage/jepgspa
dc.publisherVirus Research - Journaleng
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.subjectSARS-CoV-2spa
dc.subjectChemical drugsspa
dc.subjectTraditional Chinese medicinesspa
dc.subjectBiological productsspa
dc.titlePotential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in Chinaspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.identifier.doihttps://doi.org/10.1016/j.virusres.2020.198057spa


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record